GlassScriptPhysician profile
Spencer Hammack
NPI 1588281448
$20,119.95
in general payments reported to CMS, 2019-2025
22 companies · $1,990 in 2025
The $1,990 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $719 · 2021: $6,162 · 2022: $5,383 · 2023: $3,187 · 2024: $2,679 · 2025: $1,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,064 · Travel and Lodging: $2,793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,063.74 |
| Travel and Lodging | $2,792.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $13,031.43 | 2021-2025 | Inbone, Infinity, Invision |
| Alpha Orthopedic Systems | $4,240.21 | 2020-2022 | |
| Integra Lifesciences Corporation | $740.73 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $495.74 | 2021-2024 | Stravix, Grafix Pl, Grafix |
| Treace Medical Concepts, INC. | $401.40 | 2025 | |
| Depuy Synthes Sales INC. | $192.05 | 2021-2023 | Healix Knotless Peek |
| Sanara Medtech INC. | $169.00 | 2023 | Celleraterx |
| Organogenesis INC. | $124.74 | 2022 | |
| Kerecis Limited | $121.07 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $117.32 | 2021 | |
| Medline Industries LP | $115.52 | 2024 | |
| Paratek Pharmaceuticals, INC. | $77.64 | 2023 | Nuzyra |
| Bsn Medical INC | $47.11 | 2022 | |
| Vericel Corporation | $47.08 | 2024 | Maci |
| Paragon 28, INC. | $39.94 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $30.81 | 2022 | |
| Osteomed LLC | $30.17 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $24.81 | 2024 | Iovera |
| Innovation Technologies INC | $22.01 | 2024 | Irrisept |
| Averitas Pharma INC. | $21.44 | 2023 | Qutenza |
| Acumed LLC | $17.87 | 2021 | |
| Sebela Pharmaceuticals INC. | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Hammack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.